Literature DB >> 1325608

Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome.

A Lacroix1, E Bolté, J Tremblay, J Dupré, P Poitras, H Fournier, J Garon, D Garrel, F Bayard, R Taillefer.   

Abstract

BACKGROUND: Corticotropin-independent nodular adrenal hyperplasia is a rare cause of Cushing's syndrome, and the factors responsible for the adrenal hyperplasia are not known.
METHODS: We studied a 48-year-old woman with Cushing's syndrome, nodular adrenal hyperplasia, and undetectable plasma corticotropin concentrations in whom food stimulated cortisol secretion.
RESULTS: Cortisol secretion had an inverse diurnal rhythm in this patient, with low-to-normal fasting plasma cortisol concentrations and elevated postprandial cortisol concentrations that could not be suppressed with dexamethasone. The cortisol concentrations increased in response to oral glucose (4-fold increase) and a lipid-rich meal (4.8-fold increase) or a protein-rich meal (2.6-fold increase), but not intravenous glucose. The infusion of somatostatin blunted the plasma cortisol response to oral glucose. Intravenous infusion of gastric inhibitory polypeptide (GIP) for one hour increased the plasma cortisol concentration in the patient but not in four normal subjects. Fasting plasma GIP concentrations in the patient were similar to those in the normal subjects; feeding the patient test meals induced increases in plasma GIP concentrations that paralleled those in plasma cortisol concentrations. Cell suspensions of adrenal tissue from the patient produced more cortisol when stimulated by GIP than when stimulated by corticotropin. In contrast, adrenal cells from normal adults and fetuses or patients with cortisol-producting or aldosterone-producing adenomas responded to corticotropin but not to GIP.
CONCLUSIONS: Nodular adrenal hyperplasia and Cushing's syndrome may be food-dependent as a result of abnormal responsiveness of adrenal cells to physiologic secretion of GIP. "Illicit" (ectopic) expression of GIP receptors on adrenal cells presumably underlies this disorder.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325608     DOI: 10.1056/NEJM199210013271402

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  46 in total

Review 1.  [Progress in molecular medicine: "laser capture microdissection"].

Authors:  S R Bornstein; H S Willenberg; W A Scherbaum
Journal:  Med Klin (Munich)       Date:  1998-12-15

Review 2.  Cushing's syndrome in children and adolescents: current diagnostic and therapeutic strategies.

Authors:  M A Magiakou; G P Chrousos
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

3.  Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland.

Authors:  Nobuhiro Miyamura; Tetsuya Taguchi; Yusuke Murata; Kayo Taketa; Shinsuke Iwashita; Kazuya Matsumoto; Takeshi Nishikawa; Tetsushi Toyonaga; Michiharu Sakakida; Eiichi Araki
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

4.  Cushing's syndrome due to ACTH-independent bilateral adrenocortical macronodular hyperplasia.

Authors:  M Terzolo; A Boccuzzi; A Ali; E Bollito; C De Risi; P Paccotti; A Angeli
Journal:  J Endocrinol Invest       Date:  1997-05       Impact factor: 4.256

Review 5.  Translational research in endocrine surgery.

Authors:  Scott K Sherman; James R Howe
Journal:  Surg Oncol Clin N Am       Date:  2013-07-26       Impact factor: 3.495

6.  Adrenocorticotropin-independent Cushing's syndrome in pregnancy related to overexpression of adrenal luteinizing hormone/human chorionic gonadotropin receptors.

Authors:  E Rask; E Schvarcz; P Hellman; J Hennings; F A Karlsson; C V Rao
Journal:  J Endocrinol Invest       Date:  2009-04       Impact factor: 4.256

7.  Cushing's syndrome due to autonomous macronodular adrenal hyperplasia: long-term follow-up after unilateral adrenalectomy.

Authors:  M Boronat; T Lucas; B Barceló; C Alameda; H Hotait; J Estrada
Journal:  Postgrad Med J       Date:  1996-10       Impact factor: 2.401

8.  ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome.

Authors:  Guillaume Assié; Rossella Libé; Stéphanie Espiard; Marthe Rizk-Rabin; Anne Guimier; Windy Luscap; Olivia Barreau; Lucile Lefèvre; Mathilde Sibony; Laurence Guignat; Stéphanie Rodriguez; Karine Perlemoine; Fernande René-Corail; Franck Letourneur; Bilal Trabulsi; Alix Poussier; Nathalie Chabbert-Buffet; Françoise Borson-Chazot; Lionel Groussin; Xavier Bertagna; Constantine A Stratakis; Bruno Ragazzon; Jérôme Bertherat
Journal:  N Engl J Med       Date:  2013-11-28       Impact factor: 91.245

9.  Adrenal cortical diseases: international case conference.

Authors:  Hironobu Sasano; Takashi Suzuki; Junji Irie; Kioko Kawai; Motohiko Aiba; Anne Marie McNicol; Hiroshi Takami
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

10.  Physiologic tailoring of treatment in resistant hypertension.

Authors:  J David Spence
Journal:  Curr Cardiol Rev       Date:  2010-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.